ARCHIVES

NCAB Review Of Cancer Control Program Finds It Has Made Substantial Progress But Has Problems

This article is from The Cancer Letter archive.

Vol. 04 No. 41 | October 13, 1978

Download PDF Visit The Full Archive

Related Articles

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

In Brief: LSU Will Be Headquarters For National Pancreatic Project; Budget For First Year Will Be $1 Million

December 6, 1974

Clinical Trials Approved By NCI

November 28, 2003

Former NCI Executive Lands Key Senate Staff Position

February 4, 1977

Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE

October 4, 2002

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007